POPULARITY
22 episodes with shared decision making
12 episodes with shared decision making
20 episodes with shared decision making
6 episodes with shared decision making
7 episodes with shared decision making
4 episodes with shared decision making
5 episodes with shared decision making
2 episodes with shared decision making
5 episodes with shared decision making
4 episodes with shared decision making
5 episodes with shared decision making
4 episodes with shared decision making
2 episodes with shared decision making
4 episodes with shared decision making
7 episodes with shared decision making
3 episodes with shared decision making
4 episodes with shared decision making
3 episodes with shared decision making
Every pregnant person deserves the information—and support—they need to make truly informed decisions about labor induction. In this episode, Dr. Rebecca Dekker talks with Dr. Ann Peralta and Kari Radoff, CNM, co-creators of Partner to Decide, a nonprofit initiative improving decision-making in perinatal care. They discuss the creation of their free, multilingual decision aid that supports families in understanding their options around routine induction of labor—and empowers them to advocate for their values, preferences, and autonomy. Ann shares how her own birth experience, shaped by access to education and privilege, sparked the creation of the tool. Kari offers insight into how the decision aid has changed conversations in clinical settings—bringing clarity, reducing bias, and fostering truly shared decision-making. Together, they illuminate how access to balanced information can reduce anxiety, improve trust, and shift the culture of perinatal care. (03:02) What Is a Decision Aid and Why It Matters (07:12) Ann's Birth Story and the Origins of Partner to Decide (11:09) Gaps in Shared Decision-Making from a Provider's Perspective (14:24) Personal Values, Intuition, and Cultural Differences (18:19) Designing the Decision Aid with Equity and Accessibility (23:49) The Power of Absolute vs. Relative Risk in Birth Conversations (25:01) Surprising Patient Feedback: From Access to Empowerment (30:31) Provider Reflections and Challenging Bias (36:11) Why “Routine” Induction Language Matters (43:59) How to Respond to Pressure or Coercion Around Induction (46:16) How to Access the Free Decision Aid and Support New Tools Resources Access the free Induction of Labor Decision Aid in seven languages: www.inductiondecisionaid.org Learn more about the nonprofit: www.partnertodecide.org For more information about Evidence Based Birth® and a crash course on evidence based care, visit www.ebbirth.com. Follow us on Instagram and YouTube! Ready to learn more? Grab an EBB Podcast Listening Guide or read Dr. Dekker's book, "Babies Are Not Pizzas: They're Born, Not Delivered!" If you want to get involved at EBB, join our Professional membership (scholarship options available) and get on the wait list for our EBB Instructor program. Find an EBB Instructor here, and click here to learn more about the EBB Childbirth Class.
Dr. Shannon McLaughlin-David discusses the complexities of cervical cancer, HPV, and the role of gynecologic oncology. The dialogue explores the emotional and clinical challenges faced by both patients and clinicians, emphasizing the importance of effective communication and empathy in patient care. The discussion also highlights the various types of gynecologic cancers, surgical interventions, and the difficult decisions patients must make regarding their treatment options. This conversation delves into the complexities of patient autonomy, the emotional challenges faced by oncologists, and the systemic incentives within healthcare that can impact patient care. The discussion also covers the evolution of cervical cancer screening guidelines, the role of HPV in cervical cancer, and the importance of patient advocacy and education regarding vaccination.Resources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://www.google.com/url?q=https://pubmed.ncbi.nlm.nih.gov/33632649/&sa=D&source=editors&ust=1746483503903350&usg=AOvVaw0SNo_jk-rzoVp85P5E3s6F ‘Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence'Chapter Codes00:00 Introduction to Cervical Cancer and HPV02:49 The Journey to Gynecologic Oncology05:57 Understanding Gynecologic Cancers09:05 Surgical Interventions in Gynecologic Oncology11:59 The Complexity of Patient Decisions15:07 Patient-Clinician Communication Challenges17:45 The Role of Empathy in Oncology21:05 Navigating Hormonal Treatments and Patient Reactions27:30 Navigating Patient Autonomy and Medical Ethics29:47 The Emotional Toll of Oncology33:00 Understanding the Healthcare System's Incentives35:58 The Role of Patient Advocacy39:05 The Evolution of Cervical Cancer Screening Guidelines51:46 HPV and Its Impact on Cervical Cancer54:48 Current Screening Protocols and HPV VaccinationConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?srsltid=AfmBOopEP5GJ-Wd2nL-HYAInrwerIVhyJw67salKT-r9Qb_gadBvbHie YouTube: https://www.youtube.com/@mantacares/videosSpotify: https://open.spotify.com/episode/0rSG16JUXGnRmOPfpJSplS?si=ayogPMUMT4eHJclXn6_5xA Apple: https://podcasts.apple.com/us/podcast/the-microbiomes-impact-on-colorectal-cancer/id1622669098?i=1000705538270 Tags & Keywords:cervical cancer, HPV, gynecologic oncology, patient communication, surgical interventions, women's health, cancer treatment, patient empathy, decision making, hormonal therapy, patient autonomy, medical ethics, oncology, healthcare system, patient advocacy, cervical cancer, HPV, screening guidelines, emotional toll, healthcare incentives#Storytelling #Identity #Representation #Authenticity #Podcast #Culture #CancerAwareness #MedicalPodcast #CancerSurvivor #Oncology #Healthcare #CancerSupport #PatientStories #CancerResearch #HealthPodcast #CancerCommunity #SurvivorStories #MentalHealth #Wellness #HealthcareInnovationDisclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.
On this episode, we delve into the concept of shared decision making (SDM) in modern hemophilia care. With insights from experts Brendan Hayes and Dr. Cedric Hermans, the discussion explores the evolution of treatment options, patient education, and the collaborative decision-making process. The conversation also highlights the development and impact of the SDM tool by the World Federation of Hemophilia, emphasizing the importance of patient empowerment and ongoing education. Guests: Brendan Hayes, MPH, CPH Cedric Hermans MD PhD FRCP Senior Advisor: Donna DiMichele, MD Hosted & Written by: Patrick James Lynch Featured Advertiser: Sanofi Subscribe to the Global Hemophilia Report Show Notes: #MyHemophiliaTruth. Real stories. Powered by Sanofi. It's time to consider the whole experience when it comes to managing hemophilia and change the conversation. Explore the full story at www.myhemophiliatruth.com Mark's Story Join Mark as he shares about his experience living with hemophilia, including the impact it had on building and maintaining relationships throughout grade school, college, dating, and raising his family. Mark also highlights how shared decision making with his healthcare providers, and strong family and caregiver support in those decisions, can make all the difference when it comes to managing the daily challenges of hemophilia. Click here to watch his story: https://www.youtube.com/watch?v=tQ8oeM0zL24&list=PLmqBxf22n4lPMpAfLe4yv8haC6Ejcp1XL&index=8 Connect with the Global Hemophilia Report Global Hemophilia Report on LinkedIn Global Hemophilia Report on X/Twitter Global Hemophilia Report on Facebook Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook BloodStream on X/Twitter
Shared decision-making often focuses on parents and caregivers working with the doctor to benefit their child's health. We are exploring the next level of shared decision-making when the patient is older, such as a teen or young adult. Tune in as board-certified allergist, Dr. Doug Mack discusses how to approach teens and how young adults can navigate and understand shared decision-making.Resources to keep you in the know:Douglas Mack, M.Sc., MDFAACT's Navigating the Food Allergy Treatment Decision ProcessYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!
Send us a textThe magic happens when educators and parents join forces as true partners in a child's education. Gone are the days when "parent involvement" meant simply attending conferences or helping with homework. Today's inclusive classrooms demand meaningful engagement where families are recognized as essential collaborators in student success.Have you ever wondered why some teacher-parent relationships flourish while others remain strained? The answer often lies in intentional communication. As a classroom teacher for ten years, I discovered that establishing positive connections before challenges arise creates a foundation of trust that transforms the educational experience. My simple strategy of scheduling "celebration calls" to a few families each week ensured every parent heard good news about their child multiple times throughout the year.The CARE framework provides a roadmap for building these crucial partnerships: Communicate Intentionally, Access and Activate Resources, Respect and Respond to Diversity, and Engage in Shared Decision Making. This episode unpacks each element with practical strategies you can implement immediately. From maintaining a 3:1 ratio of positive to challenging conversations to providing multilingual resources that honor diverse family backgrounds, these approaches recognize a fundamental truth: the parent is the expert on their own child.Research consistently shows that when parents and teachers collaborate effectively, students experience higher academic achievement, improved behavior, enhanced social-emotional skills, and increased self-advocacy. Yet many families—particularly those with diverse learners—feel disconnected from schools due to previous negative experiences, language barriers, or overwhelming information. By acknowledging these challenges and implementing thoughtful engagement strategies, educators can create classrooms where every child and family feels valued, understood, and empowered. Ready to transform your parent partnerships? Start with just one strategy this week and watch what happens!You can purchase our CARE Framework here: COME SAY Hey!! Instagram: @cultrallyjebeh_ Facebook: @JebehCulturalConsulting Pinterest: @Jebeh Cultural Consulting LinkedIn: @Jebeh Cultural Consulting Leave a Review on our Podcast! We value your feedback!Buy My eBook: Empowering Your BIPOC Students Enroll In My Digital Course: How To Be A Culturally Competent LeaderBuy My K-12 Lesson PlansSign Up For Our Newsletter Enjoy the Cultural Curriculum Chat podcast? Share the love! Refer a friend to Buzzsprout and both you and your friend will enjoy exclusive benefits. Click the link to get started and support our mission of promoting inclusivity! #SpreadTheWord #CulturalCurriculumChat
Ärzte und Patienten auf Augenhöhe? Patienten, die bei der Entscheidungsfindung mitwirken? Das Programm Shared Decision Making (SDM) macht es möglich. Das vor acht Jahren am UKSH in Kiel gestartete Programm hat seine Vorteile längst unter Beweis gestellt und gilt als Erfolgsmodell. Prof. Friedemann Geiger erläutert im Podcast, was er mit SDM noch erreichen möchte.
Nurses Out Loud – We explore how technology can support informed consent, not suppress it. Ashley opens the discussion by welcoming listeners into the heart of the health freedom movement, where questions are welcome, critical thinking is encouraged, and real transparency matters. As the creator of VaxCalc and its AI companion, VaxBot, Chris Downey's helping families break down complex vaccine data...
Nurses Out Loud – We explore how technology can support informed consent, not suppress it. Ashley opens the discussion by welcoming listeners into the heart of the health freedom movement, where questions are welcome, critical thinking is encouraged, and real transparency matters. As the creator of VaxCalc and its AI companion, VaxBot, Chris Downey's helping families break down complex vaccine data...
In this insightful conversation, Dr. Beau Beard sits down with Dr. Steven Capobianco—clinician, educator, and fascia researcher—to unpack the evolving landscape of manual therapy, pain science, and movement-based care.From the history of trigger points and Travell & Simons to modern fascia research from Stecco, they challenge outdated paradigms and offer a fresh framework for integrating touch, neuroscience, and patient-centered care.Topics include:- Why trigger points are still debated—and why they still matter- Fascia's role in pain and movement, beyond the hype- Rethinking touch: from mechanical to neurological- How to implement the biopsychosocial model with clarity and confidence- The rise in chronic pain—and what clinicians might be missingThis is not about pushing techniques—it's about elevating clinical reasoning. Whether you're a chiropractor, physio, trainer, or just fascinated by how the body works, this is a must-listen.***Chapters00:00 Introduction and Personal Updates05:18 Experiences at the Fix Congress08:40 Fascia and Its Importance in Manual Therapy10:34 The Bio-Psycho-Social Model in Treatment14:10 Historical Context of Manual Therapy22:50 The Evolution of Trigger Point Research32:37 The Controversy of Fascia and Manual Therapy35:36 Curiosity in Evidence-Based Practice39:03 The Complexity of Pain and Movement41:30 The Role of Touch in Therapy50:53 Centrally Mediated Pain and Trigger Points56:54 The Importance of Patient Expectations and Data Gathering01:07:28 Understanding Pain Beyond Treatment01:10:32 The Role of Curiosity in Pain Management01:13:08 The Global Burden of Pain and Movement01:16:26 The Complexity of Trigger Points01:20:51 Shared Decision Making in Therapy01:22:14 Exploring the Causes of Rising Pain Rates01:26:31 The Interplay of Pain, Anxiety, and Movement01:30:35 The Evolving Role of Touch in Therapy01:41:14 The Role of Touch in Movement and Pain Management01:44:28 Exploring Movement and Pain Perception01:46:41 The Interplay of Touch, Breath, and Awareness01:51:53 Understanding Pain and Movement Patterns02:01:34 The Importance of Patient Interaction and Experience02:04:02 Frameworks for Understanding Movement and Pain
In this episode, Dr. Eleanor Bimla Schwartz and Dr. Kelly Treder discuss the misconceptions of tubal sterilization, including debunking notions that is it 100% fool-proof, that the surgery is reversible, that it is more effective than other contraceptive options, or that there is little to no pain post-surgery. “I think we do have fairly widespread misunderstanding of what it means to have your tubes tied. A lot of people seem to have the understanding that that would be something you could easily untie and that it would be a procedure that you could undo,” Dr. Schwartz says. They highlight how important it is for providers to be transparent with patients about long-acting contraception options (arm implant, IUD, vasectomy) and their effectiveness with preventing pregnancy, side effects, cost, accessibility, and longevity compared to surgery. Because of this, it is crucial for providers to be informed about the nuances of different contraceptive options. Dr. Schwartz and Dr. Treder provide firsthand insight into what difficult conversations surrounding contraceptives with patients can look like. “I think it's just our obligation to make sure that they know about all available options, that they're not arriving at this decision that they need to have a surgery because they think it's the only thing that's safe for them or the only thing that will work well for them,” says Dr. Schwartz. This episode is a follow up to S4 E5 Lesser-Known Forms of Birth Control and Downplayed Side-effects: Providing Empowering Contraceptive Carewith Dr. Karlin and health educator Mariana Horne. Click here to view the episode transcript. Resources recommended in the episode: Bedsider.org is an online resource designed to help individuals explore, compare, and access birth control options. Bedsider offers a comprehensive description of various contraceptive methods, such as IUDs, implants, pills, and sterilization using interactive tools, real-life stories, and educational content. Advancing Access is a UCSF resource that provides clear, evidence-based information on long-acting reversible and non-reversible birth control methods, including costs, benefits, and where to access care. https://www.cdc.gov/nchs/nsfg/index.htm - National Survey of Family Growth CAPTC related trainings and resources - Shared Decision Making in Contraceptive Counseling - Person-Centered Contraception Counseling for Family Pact Clients - Same-Day Placement of LARC: Solutions to Common Barriers Brief Bio Dr. Eleanor Bimla Schwartz Dr. Schwartz, MD is a professor of medicine at UCSF and the chief of the Division of General Internal Medicine at the San Francisco General Hospital. She has a particular interest in identifying ways to meet the needs of diverse populations, including women with chronic medical conditions and other underserved populations. Dr. Treder Dr. Kelly Treder, MD, MPH, is a board-certified OB-GYN at Boston Medical Center and an assistant professor of OB-GYN at Boston University School of Medicine. She specializes in family planning and is committed to health equity.
For patients who are older, or with complex diseases like HCM, healthcare professionals who really listen can be the key to successful shared decision-making. Guest Kate Lew, MSN, RN, FNP-C, FPCNA, addresses effective strategies, a well as how to get involved beyond the clinical walls.PCNA Heart Healthy Toolbox: https://pcna.net/clinical-resources/patient-handouts/heart-healthy-toolbox/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
MS-Perspektive - der Multiple Sklerose Podcast mit Nele Handwerker
Der MS-Zwilling ermöglicht ein ganzheitliches Management der Gesundheit von MS-Patienten von Arzt und Betroffenen gemeinsam. Erfahre mehr. Das Interview zum Nachlesen findest Du auf meinem Blog: https://ms-perspektive.de/300-ms-zwilling In dieser ganz besonderen Jubiläumsfolge spreche ich mit Prof. Dr. Tjalf Ziemssen über ein visionäres Konzept: den digitalen Zwilling für Menschen mit Multipler Sklerose. Was zunächst futuristisch klingt, könnte schon bald Realität werden – und unser Verständnis von MS-Therapie grundlegend verändern. Wir sprechen darüber, wie medizinische Daten sinnvoll genutzt werden können, warum personalisierte Vorhersagen und KI-basierte Entscheidungen neue Möglichkeiten in der Behandlung eröffnen und wie ein hybrides Versorgungssystem den Alltag von Patient:innen erleichtern kann. Besonders spannend: Der digitale Zwilling soll nicht nur Ärzt:innen unterstützen, sondern auch MS-Betroffene stärken – als eine Art intelligenter Gesundheitsbegleiter im Alltag.
MS-Perspektive - der Multiple Sklerose Podcast mit Nele Handwerker
Erfahre wie Dir KI dabei helfen kann ein strukturierteres Arztgespräch zu bekommen, bei dem Du alle Dir wichtigen Punkte ansprechen kannst. Du kannst den Beitrag auf meinem Blog Nachlesen: https://ms-perspektive.de/299-arztgespraech Heute geht es darum, wie Du mithilfe der KI, zum Beispiel ChatGPT, Dein Arztgespräch besser vorbereiten kannst. Ich bin jedes Quartal einmal im MS-Zentrum Dresden und in all den Jahren ist es mir oft genug passiert, dass ich wichtige Themen vergaß anzusprechen. Das hatte unterschiedliche Gründe. Vermutlich kennst Du das. Wenn Ergebnisse präsentiert werden, mit denen man nicht gerechnet hat, Begriffe fallen, die neu oder zumindest nicht vertraut genug sind, dass man ins Grübeln kommt. Und bei einer chronischen Erkrankung, wie Multipler Sklerose kann es durchaus mehrere Themen geben, die im Gespräch mit der Ärztin oder dem Arzt diskutiert werden sollen. Die Zeit ist meist knapp – und aufgeregt, vergisst man leicht die Hälfte. Ich habe festgestellt, dass ChatGPT mir dabei helfen kann, solche Gespräche gezielt vorzubereiten. In dieser Folge zeige ich Dir, wie das konkret funktionieren kann. Und zwar anhand eines praktischen Beispiels. Inhaltsverzeichnis Warum ist Vorbereitung so wichtig? Ein Beispiel aus der Praxis: MS und ChatGPT Wie baue ich so ein Gespräch auf? Fazit und Einladung Fazit und Einladung ChatGPT ist kein Wundermittel – aber ein ziemlich guter Assistent. Und deshalb finde ich es wichtig, dass Du immer höflich mit der KI sprichst. Ansonsten gewöhnst Du dir womöglich einen unhöflichen Befehlston an und nutzt diesen gegenüber echten Menschen. Das wäre eine traurige Entwicklung. Bitte und Danke sollten immer enthalten sein. Wenn Du das Gefühl hast, beim Arzt nicht alles rüberzubringen oder Du Deine Gedanken sortieren willst: Probiert's einfach mal aus. Wenn Du magst, teile ich auch gern nochmal ein paar Prompts oder mache eine Folge mit anderen konkreten Beispielen. Schreib mir gern, wenn Du Feedback oder Fragen hast! Ach und falls Du bei einer KI das kostenlose Kontingent erschöpft hast, dann probiere einfach eine andere aus. Ich nutze einen Bezahlaccount, dadurch sind mir keine Grenzen gesetzt. Aber es gibt zum Glück viele Anbieter. --- Bis bald und mach das Beste aus Deinem Leben, Nele Mehr Informationen und positive Gedanken erhältst Du in meinem kostenlosen Newsletter. Hier findest Du eine Übersicht zu allen bisherigen Podcastfolgen.
Personalized therapeutic approaches for the treatment of chronic lymphocytic leukemia (CLL), guided by shared decision-making, can improve outcomes by aligning treatment with a patient's unique clinical profile, preferences and goals. The Association of Cancer Care Centers (ACCC) is dedicated to providing up-to-date information on CLL management and treatment strategies. In this episode, CANCER BUZZ speaks with Christopher Nelson, ACNP, MBA, certified oncology nurse practitioner at Avera Medical Group Oncology & Hematology, to explore the importance of shared decision-making and patient communication in CLL. Additionally, CANCER BUZZ speaks with Meghan McGrath, MSN, RN, AGACNP, clinical trial nurse navigator at The Leukemia and Lymphoma Society (LLS), who discusses ways to incorporate clinical trials in the shared decision-making process and LLS services that are available to support patients and providers. “You do what the patient feels is best, you know, you look at what their values are and what's important to them, and then you try to find a therapy that fits those.” – Christopher Nelson, ACNP “I think it's really important to try and make every patient aware of the fact that a clinical trial could be right for them at any stage in the game.” – Meghan McGrath, MSN, RN, AGACNP Christopher Nelson, ACNP Oncology Nurse Practitioner Avera Medical Group Oncology & Hematology Aberdeen, SD Meghan McGrath, MSN, RN, AGACNP Clinical Trial Nurse Navigator The Leukemia and Lymphoma Society (LLS) Resources: · ACCC Treatment for Double-Exposed CLL - https://bit.ly/4iSmfV1 · ACCC CLL Resources - https://bit.ly/3E4QqZK · LLS Clinical Trial Support Center - https://bit.ly/42sqGQk · ACCC CLL Video Series - https://bit.ly/4la4li5
Shared decision-making is essential to the care of patients with advanced renal carcinoma which can empower patients and help the healthcare team understand the patient's goals of care. Identification and management of treatment-related adverse events is key to this. In this podcast, a patient author and two healthcare professionals with real-world experience provide insight into the importance of shared decision-making and its utility in the management of treatment-related adverse events in patients with renal cell carcinoma who are receiving axitinib in combination with an immunotherapy agent. This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-025-00330-w. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.
In this episode of Game Over: c*ncer, hosts Dana Nichols and Val Solomon dive into the complex and emotional tightrope of balancing hope and reality in pediatric cancer. Joining the conversation is Dr. Claire Wakefield, a psychologist, researcher, and professor specializing in pediatric psycho-oncology. Dr. Wakefield leads the Behavioral Sciences Unit at UNSW and Sydney Children's Hospital, one of the largest pediatric cancer survivorship research groups in the world. Together, we explore the psychological and emotional challenges families face when navigating new treatment options, clinical trials, and difficult medical decisions. Dr. Wakefield shares her insights on ethical best practices, shared decision-making, and the evolving landscape of pediatric cancer care—ensuring that families receive not only medical support but also the guidance and resources needed for their well-being. Key Topics Covered:- The intersection of pediatric cancer treatment, psychology, and hope - How families process and make decisions about clinical trials - The impact of new medical technologies on patient experiences - Supporting children and parents through the hardest moments - The global disparities in pediatric cancer treatment and efforts to bridge the gap This thought-provoking conversation is a must-listen for anyone passionate about advancing pediatric cancer research and supporting families in the fight. Support the mission visit us at: https://www.cannonballkidscancer.org to make a gift and help fund innovative research.----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/
In the second of a two-part podcast from the Centre for Perioperative Care and the Royal College of Anaesthetists former CPOC Fellow Dr Sam Moore and Dr Stuart Connal explore shared decision making - its definitions, usage, and many nuances in the interaction between clinicians and patients. This podcast features guests Dr Sam Finnikin, Dr Gemma Hughes, and Leila Finikarides, and is split into two separate episodes. Sam, Gemma, and Leila share their personal and professional perspectives on shared decision-making - its importance in the patient-clinician relationship, language, and even when the idea of a shared decision may be counterproductive. For ideas to benefit your own clinical practice, and for insights into the latest research and practices in this area, make sure you listen to both parts of this fascinating conversation.
In this first of a two-part podcast from the Centre for Perioperative Care and the Royal College of Anaesthetists former CPOC Fellow Dr Sam Moore and Dr Stuart Connal explore shared decision making - its definitions, usage, and many nuances in the interaction between clinicians and patients. This podcast features guests Dr Sam Finnikin, Dr Gemma Hughes, and Leila Finikarides, and is split into two separate episodes. Sam, Gemma, and Leila share their personal and professional perspectives on shared decision-making - its importance in the patient-clinician relationship, language, and even when the idea of a shared decision may be counterproductive. For ideas to benefit your own clinical practice, and for insights into the latest research and practices in this area, make sure you listen to both parts of this fascinating conversation. Listen out for the second episode which will be released the following week.
Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health's three-part microlearning series, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With new advances in developing MCED testing and implementing it into practice, Dr. Vega sat down with us again to share additional insights from Module 3 of the activity, including questions he commonly gets from patients about MCED testing and advice for clinicians about employing shared decision making with patients to choose the most appropriate type of cancer screening for them. Afterwards, stay tuned to hear the full activity and learn how to claim CME credit. Click here to claim your CME credit: https://bit.ly/4b9JU00
Kennst Du genomDE und das Modellvorhaben Genomsequenzierung?Dieses startete im Juli 2024 an den beteiligten klinischen Zentren. Über einen Zeitraum von fünf Jahren wird die Genomsequenzierung bei Betroffenen mit Krebs und Seltenen Erkrankungen bundesweit einheitlich ermöglicht. Die Leistungen im Rahmen des Modellvorhabens werden mit 700 Millionen Euro von den gesetzlichen Krankenkassen finanziert.In dieser Folge spreche ich auf Augenhöhe über dieses Modellvorhaben und vielen Themen bzgl. dieses Projektes mit:Dr. Ina Pretzell, Oberärztin Molekulares Tumorboard und molekulare Diagnostik am Westdeutschen Tumorzentrum in EssenDr. Benedikt Westphalen (siehe auch 125. Talk), Ärztlicher Leiter der Präzisionsonkologie am LMU Klinikum München und den jungen Krebs Patient*innenMarijke, 40, lebt seit 3 Jahren mit metastasierten LungenkrebsBastian Schwarz, 33, lebt seit 4,5 Jahren mit dem seltenen metastasierten alveolärem Weichteilsarkom Unser Ziel ist es, aufzuklären und ein besseres Verständnis für die Chancen, aber auch begrenzten Möglichkeiten zu schaffen. Dabei sprechen wir offen über unsere Erfahrungen anhand konkreter Beispiele.Unser Resümee:Nur gemeinsam können wir Veränderungen im Gesundheitssystem vorantreiben und bestehende Lücken schließen.Ein großes Dankeschön an Socentic Studio München, die uns diese Aufnahme ermöglicht haben:
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
In this podcast recorded in early January, David Phizackerley provides a brief overview of the February 2025 issue of DTB. The editorial discusses the importance of shared decision making and calls on guideline developers to produce patient decision aids to accompany their guidance - https://dtb.bmj.com/content/63/2/18. A DTB Select item summarises a study that evaluated implementation of NHS England's type 2 diabetes path to remission programme - https://dtb.bmj.com/content/63/2/19. The authors of a DTB Commentary article review a UK primary care study which reported that treatment with antihypertensive medicines in older people with complex health needs was associated with an increased risk of acute kidney injury (AKI) and a short-term increased risk of falls - https://dtb.bmj.com/content/63/2/20. The main article explores the evidence for gefapixant in the treatment of refractory or unexplained chronic cough in adults - https://dtb.bmj.com/content/63/2/22. Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.
CME credits: 1.25 Valid until: 31-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-power-of-shared-decision-making-in-obesity-care/29935/ Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning activities will provide tips and tools for the implementation of key obesity interventions, including nutritional, physical, behavioral, and pharmacological approaches. Partner with your patients and recognize the importance of treating obesity like any other chronic condition.
Impfskepsis überwinden: Strategien für die hausärztliche Praxis
Improve your shared decision-making (SDM), no matter how you do it. Just like it says on the label, today’s episode is a quick exercise to help you improve your shared decision-making, no matter how you do shared decision-making. Hi everybody, I'm Dr. Anne Marie Liebel, and this is 10 Minutes to Better Patient Communication from […] The post A quick exercise to help your shared decision-making appeared first on Health Communication Partners.
This 30-minute CME-accredited program, hosted by John Kuruvilla, MD, discusses best practices for talking to patients with hematologic malignancies about possibly participating in clinical trials.Jointly Provided by American Academy of CME and CheckRare CE.Support for this accredited continuing education activity has been made possible through educational grant from Merck.Estimated time to complete: 0.5 hours Start date: November 30, 2024End date: November 30, 2025 Activity FacultyJohn Kuruvilla, MDHematologist / Clinical InvestigatorPrincess Margaret Cancer CentreProfessor of MedicineUniversity of Toronto Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in hematology-oncology. Other healthcare providers, including NPs and PAs, may also participate. Learning ObjectivesAfter participating in the activity, learners should be better able to- Describe the importance of clinical trials in furthering the science of hematologic malignancies treatment.- Describe and utilize best practices for engaging patients in shared decision making regarding clinical trial participation. Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows: Faculty Educator/PlannerDr. Kuruvilla discloses the following relevant financial relationships with ineligible companies:Honoraria: AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Beigene, Genmab, Gilead Sciences, GlaxoSmithKline, Incyte, Janssen, Karyopharm, Merck, Novartis, Pfizer, Roche, Seattle GeneticsConsultant: AbbVie, Bristol Myers Squibb, Gilead Sciences/Kite, Merck, Roche, Seattle GeneticsGrant/Research Support: AstraZeneca, Kite, Merck, Novartis, RocheData Safety Monitoring Board: KaryopharmPlanners for this activity have no relevant financial relationships with any ineligible companies. This activity will not review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Method of ParticipationThere are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please go to https://checkrare.com/learning/p-hematologic-malignancies-and-clinical-trial-participation-a-shared-decision-making-approach/ PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.org
Please visit answersincme.com/KWX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in bipolar disorder and a patient advocate discuss patient-centered care for people with bipolar I. Upon completion of this activity, participants should be better able to: Identify patient-centered strategies to optimize the timely diagnosis of bipolar I disorder (BD-I); Review goal-oriented therapeutic approaches that address the personalized needs of patients with BD-I; and Outline strategies to ensure the delivery of patient-centric care that incorporates patients' wishes, values, priorities, and goals.
How do you care for patients with penile cancer? As urologists, we're trained to think about diagnosis and treatment, but how can we help manage the psychological impacts of penile cancer? In this episode of BackTable Urology, host Dr. Ben Ayres, a urologic oncologist specializing in penile cancer, discusses the unique psychological challenges faced by penile cancer patients with bladder cancer survivor Dr. Rick Bangs and nurse Rob Cornes. --- This podcast is supported by: Photocure https://www.photocure.com/ --- SYNPOSIS This episode emphasizes the importance of awareness and peer support in reducing isolation and stigma associated with penile cancer. The conversation also explores the role of multidisciplinary care and the benefits of holistic approaches to patient decision-making. --- TIMESTAMPS 00:00 - Introduction 04:05 - Isolation in Penile Cancer 06:38 - The Role of Advocacy and Peer Support 15:29 - Shared Decision Making in Penile Cancer Care 23:22 - Value of Multidisciplinary Care --- RESOURCES Photocure https://www.photocure.com/ Global Society of Rare GU Tumors (GSRGT) https://www.gsrgt.com
Shared Decision Making - Patienten, Ärzte und Pflegekräfte finden gemeinsam über die beste Behandlung. Wie kann das gelingen? In Bayern wurde dazu ein großangelegtes Projekt gestartet. Das Gesundheitsgespräch probiert es aus.
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at Mayo Clinic and director of pharmacy at Minnesota Oncology, about shared decision making in the management of relapsed or refractory mantle cell lymphoma. “The key to all of this is good collaboration between the community and their affiliates… their partners and academics, or tertiary referral centers, to really engage… these patients in a collaborative format… it really takes a team, a village, to take care of complex mantle cell lymphoma patients. “ –Dr. Nirav Shah, MD, MSHP “We're not really seeing a lot of CAR T-cell therapy move in the frontline setting just yet, while there are a lot of ongoing clinical trials… Really, right now, it's going to be the patient characteristic: how well they did on frontline therapy, access to care, affordability, institutional preparedness… that would potentially… allow your patient to receive CAR T-cell therapy.” –Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Nirav Shah, MD, MSHP Associate Professor of Medicine Medical College of Wisconsin Division of Hematology and Oncology Milwaukee, Wisconsin Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Assistant Professor of Pharmacy, Mayo Clinic Director of Pharmacy Minnesota Oncology St. Paul, Minnesota This project is made possible by funding and support provided by Eli Lilly and in collaboration with The Leukemia & Lymphoma Society. Resources Treatment for Relapsed/Refractory Mantle Cell Lymphoma Tip Sheet - ACCC Relapsed/Refractory Mantle Cell Lymphoma Educational Video Series: Update on New Therapies: https://vimeo.com/942756449 BTK Inhibitors in MCL: https://vimeo.com/942755401 R/R MCL Case Studies: https://vimeo.com/942754652 BTK Inhibitors Stretch Frontline Approaches in Mantle Cell Lymphoma – Targeted Oncology Emerging Data Continue to Affect BTK Inhibitor Usage in Mantle Cell Lymphoma - OncLive HCP Fact Sheet: Facts About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2023-10/FSHP1_CART_Factsheet_June2022_rev.pdf The CAR T-cell Therapy Process - https://www.lls.org/sites/default/files/2024-03/PS100_CART-CellTherapyProcessFlyer_0224.pdf Patient-Caregiver CAR T-cell Therapy Facts - https://www.lls.org/sites/default/files/2024-04/FS27_CART_Fact_Sheet_0424_rev.pdf Learn About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2024-03/PS126_CART_ResourceCard_3_24.pdf Mantle Cell Lymphoma Facts for Patients and Caregivers -The Leukemia & Lymphoma Society https://lls.org/sites/default/files/2023-08/FS4_Mantle_Cell_Facts_0423rev.pdf
If you have been wondering if there is a better way to develop an engaged, empowered organizational culture - one where employees feel a sense of ownership and power to make a difference, both internally on their teams and even as far as making a global impact, this is the episode for you. ***WHAT YOU WILL LEARN:In this episode, you will hear practical examples of how various organizations developed engaged, empowered corporate cultures, how these organizations got started, and the impact it can have on people and the planet, including how this can impact health at a global level.***ABOUT OUR GUEST:Lorraine Margherita is a bilingual collaborative consultant, author and speaker. She is a catalyst of participatory environments and partners with teams and organizations to help them remove the barrier between decision and action. With a proven track record of empowering over 7,000 leaders and managers at major global corporations in a variety of industries, she is recognized for her pivotal role in facilitating transformative change, building on her systemic and appreciative approach. Lorraine is the author of Shared Decision-Making in the Corporate Arena, an exploration into multiple industries and organizations that have fostered a culture of impact by empowering their teams. Lorraine holds degrees from Dauphine University in Paris, Sciences Po Lyon and was an exchange student at Georgetown University (Washington, DC). Since then she has completed a number of certifications to facilitate large groups, foster innovation and handle systemic change.***IF YOU ENJOYED THIS EPISODE, CAN I ASK A FAVOR?We do not receive any funding or sponsorship for this podcast. If you learned something and feel others could also benefit, please leave a positive review. Every review helps amplify our work and visibility. Thisis especially helpful for small women-owned boot-strapped businesses. Simply go to the bottom of the Apple Podcast page to enter a review. Thank you!***LINKS MENTIONED IN EPISODE:Guest LinkedIn Profile: https://www.linkedin.com/in/lorraine-margherita-collective-dynamics-for-governance-and-performance/Guest Website: https://co-dynamics.net/en/Our website: www.gotowerscope.com#empowerment #autonomy #responsibility #DecisionMaking #culture #TheHardSkills #OrganizationalImpactTune in for this empowering conversation at TalkRadio.nyc
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at Mayo Clinic and director of pharmacy at Minnesota Oncology, about shared decision making in the management of relapsed or refractory mantle cell lymphoma. “The key to all of this is good collaboration between the community and their affiliates… their partners and academics, or tertiary referral centers, to really engage… these patients in a collaborative format… it really takes a team, a village, to take care of complex mantle cell lymphoma patients. “ –Dr. Nirav Shah, MD, MSHP “We're not really seeing a lot of CAR T-cell therapy move in the frontline setting just yet, while there are a lot of ongoing clinical trials… Really, right now, it's going to be the patient characteristic: how well they did on frontline therapy, access to care, affordability, institutional preparedness… that would potentially… allow your patient to receive CAR T-cell therapy.” –Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Nirav Shah, MD, MSHP Associate Professor of Medicine Medical College of Wisconsin Division of Hematology and Oncology Milwaukee, Wisconsin Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Assistant Professor of Pharmacy, Mayo Clinic Director of Pharmacy Minnesota Oncology St. Paul, Minnesota This project is made possible by funding and support provided by Eli Lilly and in collaboration with The Leukemia & Lymphoma Society. Resources Treatment for Relapsed/Refractory Mantle Cell Lymphoma Tip Sheet - ACCC Relapsed/Refractory Mantle Cell Lymphoma Educational Video Series: Update on New Therapies: https://vimeo.com/942756449 BTK Inhibitors in MCL: https://vimeo.com/942755401 R/R MCL Case Studies: https://vimeo.com/942754652 BTK Inhibitors Stretch Frontline Approaches in Mantle Cell Lymphoma – Targeted Oncology Emerging Data Continue to Affect BTK Inhibitor Usage in Mantle Cell Lymphoma - OncLive HCP Fact Sheet: Facts About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2023-10/FSHP1_CART_Factsheet_June2022_rev.pdf The CAR T-cell Therapy Process - https://www.lls.org/sites/default/files/2024-03/PS100_CART-CellTherapyProcessFlyer_0224.pdf Patient-Caregiver CAR T-cell Therapy Facts - https://www.lls.org/sites/default/files/2024-04/FS27_CART_Fact_Sheet_0424_rev.pdf Learn About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2024-03/PS126_CART_ResourceCard_3_24.pdf Mantle Cell Lymphoma Facts for Patients and Caregivers -The Leukemia & Lymphoma Society https://lls.org/sites/default/files/2023-08/FS4_Mantle_Cell_Facts_0423rev.pdf
Chris Hughen sat down with Julie Ayre and Hazel Jenkins to discuss Shared Decision-Making. We dive into the purpose of shared decision-making, how to practically implement it into practice, decision aids and their utility for both patients and clinicians, and much more. Watch the full episode: https://youtu.be/oNwkgjmnFR8 Resources: Decision Aid Library A Decision Aid for Patients Considering Surgery for Sciatica: Codesign and User‐Testing With Patients and Clinicians Julie's Twitter Julie's ResearchGate Hazel's Twitter Hazel's ResearchGate --- Follow Us: YouTube: https://www.youtube.com/e3rehab Instagram: https://www.instagram.com/e3rehab/ Twitter: https://twitter.com/E3Rehab --- Rehab & Performance Programs: https://store.e3rehab.com/ Newsletter: https://e3rehab.ck.page/19eae53ac1 Coaching & Consultations: https://e3rehab.com/coaching/ Articles: https://e3rehab.com/articles/ Apparel: https://store.e3rehab.com/collections/frontpage --- Podcast Sponsors: Vivo Barefoot: Get 20% off all shoes! - https://www.vivobarefoot.com/e3rehab --- @dr.surdykapt @tony.comella @dr.nicolept @chrishughen @nateh_24 --- This episode was produced by Matt Hunter
In episode 583, Mike and James continue to go over the issues associated with using CVD risk calculators. We talk about some of the limitations, how to think about the results and explain the risks and benefits to patients. Show notes PEER Simplified Cardiovascular Decision Aid Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 […]
In this episode, Cheryl Crow and Dr. Liana Fraenkel dive into the crucial concept of "Shared Decision Making" (SDM) in rheumatoid arthritis care. SDM is a collaborative approach where patients and doctors work together to develop a treatment plan. It empowers patients to express their preferences and values, while doctors listen actively and consider these when recommending treatments.The discussion also touches on the role of education in SDM, especially when it comes to understanding the pros and cons of different medications. Cheryl and Dr. Fraenkel address medication hesitancy, highlighting research that shows how patients benefit from hearing not only from their doctors but also from others who have firsthand experience with rheumatic disease medications.Finally, Dr. Fraenkel and Cheryl emphasize the importance of ongoing research in rheumatology and the need to strengthen the rheumatology workforce, given the current shortage. They explore the efforts of the Rheumatology Research Foundation and discuss ways for patients to get involved in supporting these vital initiatives.Medical disclaimer:All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! For full episode details including a video and transcript:Go to the episode page on the Arthritis Life Website.
Effective communication between patients and healthcare providers is crucial to facilitate shared decision-making and meaningful dialogue that supports improved patient outcomes in diffuse large B-cell lymphoma (DLBCL) care. In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider relationship. “I think empathy is a key part of establishing a relationship between a provider and a patient. [It] helps the patient feel safe when they're dealing with what can be a very stressful and frightening situation...A phrase that I like to use: ‘Our care team is going to take care of you. We are here for you during this diagnosis, and we're going to take care of you as you move through your care plan.'” — Jean Louise Koff, MD, MSc Jean Louise Koff, MD, MSc Associate Professor Department of Hematology and Oncology Winship Cancer Institute Emory University School of Medicine Atlanta, GA This video podcast was produced in partnership with the Leukemia and Lymphoma Society and made possible by support from Abbvie, Genmab, and Genentech. Resources · Reframing the Conversation: Effective Practices for Diffuse Large B-Cell Lymphoma - ACCC · DLBCL Communication Roadmap - ACCC
Join Laura Arroyo, host of Our Forever Smiles, in a heartfelt conversation with Micha Clark, a neonatal intensive care feeding therapist, as they explore the complexities of NICU experiences. From discussing the various reasons children end up in the NICU to sharing invaluable tips on caring for both your baby and yourself during this challenging time, they offer practical advice and empathetic support. Micha sheds light on how parents can effectively advocate for their feeding goals when faced with medical professionals who may not fully understand or support their needs. Whether you're a parent going through this journey or simply curious about NICU care, this episode provides invaluable insights and encouragement. Connect with Micha Clark on Instagram @Micha_Clark Want to share your story? Email us at ourforeversmiles@gmail.com. Want to be a show sponsor? Email us at ourforeversmiles@gmail.com Follow us @ourforeversmiles on social platforms We know you will have questions! Join our FB Community to discuss the weekly episode and speak directly to our guests. https://www.facebook.com/groups/1081522212884073/ *Correction: The American Academy of Pediatrics was referred to as the Academy of American Pediatrics. _______________________________________________________________________________ This podcast is completely free for you, but if you'd ever consider supporting the show, we truly appreciate it. One way you can do that is by using our affiliate links. These are links to products we've mentioned on the show, and if you make a purchase through one of them, we might earn a small commission at no extra cost to you. It's a great way to show your love for the podcast and help us keep creating content that educates, empowers, and strengthens the cleft lip and palate community! First Bottle to Purchase After Palate Repair - Post Palate Repair Straw Trainer Juselle's Cleft Palate Bottle - Pigeon Bottle Specialty Feeder Sippy Cup for Pre Palate Repair Prep - Munchkin 360 Weigh your Baby at Home - Weighted Feeds Scale Squeezable Straw Training Bottle - Honey Bear Straw Cup Free Flow Cup for Pre palate Repair Prep - Reflo Smart Cup Pacifiers that have Worked for Cleft Lip and Palate Babies - Itzy Ritzy Pacifiers that have Worked for Cleft Lip and Palate Babies - MAM Pacifiers that have Worked for Cleft Lip and Palate Babies - Itzy Ritzy Scar Cream Recommended by Alexis Garcia, Cleft Lip Mom - bioCorneum - Pricey**
SummaryIn this episode we chat with Dr. Romy Ghosh about what pregnancy care looks like when under the care of an Obstetrician. She chimes in on routine tests and procedures in pregnancy, including dating ultrasounds, prenatal labs, and genetic testing. She explains the importance of these tests and how they help monitor the health of both the mother and baby. Dr. Ghosh also talks about the vaccines offered during pregnancy, such as Tdap, RSV, and flu vaccinations. She highlights the role of RhoGAM in preventing complications for Rh-negative mothers. The conversation emphasizes the importance of patient education and the benefits of collaborative care with doulas. In this conversation, Dr. Romy Ghosh discusses various aspects of prenatal care and what patients can expect during pregnancy and childbirth. She emphasizes the importance of individualized care and shared decision-making, highlighting the need for patients to find a provider who aligns with their preferences and values. Dr. Ghosh also discusses the significance of certain tests and procedures, such as the 20-week scan and gestational diabetes testing. She explains the routine procedures during labor and the immediate postpartum period, including the administration of postpartum Pitocin and vitamin K. Overall, the conversation emphasizes the importance of trust, communication, and personalized care in ensuring a positive birthing experience. TakeawaysRoutine tests and procedures in pregnancy include dating ultrasounds, prenatal labs, and genetic testing.Vaccines offered during pregnancy include Tdap, RSV, and flu vaccinations.RhoGAM is important for Rh-negative mothers to prevent complications.Patient education is crucial in understanding the purpose and benefits of these tests and vaccines.Collaborative care with doulas can provide additional support and guidance throughout pregnancy. Finding a provider who offers individualized care and aligns with your preferences is crucial for a positive birthing experience.Certain tests and procedures, such as the 20-week scan and gestational diabetes testing, are highly recommended for their potential to detect abnormalities and ensure the well-being of both the mother and baby.During labor, routine procedures include monitoring vital signs, checking the cervix, and administering postpartum Pitocin to prevent postpartum hemorrhage.The immediate postpartum period involves evaluating the placenta, assessing for tearing, and administering erythromycin, vitamin K, and hepatitis B vaccination to the baby.Open communication, trust, and shared decision-making between the patient and provider are essential for a positive birthing experience.Patients should research and interview potential providers and consider seeking recommendations from labor and delivery nurses. Dr. Romy Ghosh, MD, FACOG can be found on Instagram here: @dr.romyghoshwww.austinregionalclinic.com/doctors/romy-ghosh Thank you to our sponsor, Birth, Baby! Academy. You can find them at www.BirthBabyAcademy.comPlease feel free to reach out to us with any recommendations for show episode ideas. If you'd like to be a guest, email us with some information about yourself and what type of podcast you'd like to record together. Thank you for all of your support and don't forget to follow and review our podcast, Birth, Baby! Instagram: @BirthBabyPodcastEmail: BirthBabyPodcast@gmail.comWebsite: https://birthbabypodcast.transistor.fm/ Intro and Outro music by Longing for Orpheus. You can find them on Spotify! (00:00) - Routine Tests and Procedures in Pregnancy (19:40) - Vaccines During Pregnancy (21:49) - RhoGAM for Rh-Negative Mothers (25:07) - Patient Education and Empowerment (26:02) - The Importance of Individualized Care and Shared Decision-Making (27:59) - Key Tests and Procedures in Prenatal Care (30:24) - The Significance of the 20-Week Scan (32:42) - Routine Procedures During Labor (36:19) - The Role of Trust, Communication, and Personalized Care (42:32) - The Immediate Postpartum Period (45:23) - Finding the Right Provider
Recorded LIVE! At Johns Hopkins Internal Medicine Grand Rounds Step up your anemia game as we explore the causes and diagnostic approach for macrocytic anemia, what to do with a reticulocyte count, the differential diagnosis for hemolytic anemia, the significance of the direct antiglobulin test, and diagnosis and management pearls for autoimmune hemolytic anemia (AIHA) and myelodysplastic syndrome (MDS). Plus, common questions and concerns regarding folate supplementation and the use of bone marrow biopsies. We're joined by hematologist and pun enthusiast Dr. Rakhi Naik MD, MHS, @redcell_doc @hopkinsheme. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Intro and Guest intro 05:53 Case 1: Elise - Macrocytic Anemia 14:59 Case 2: Jane - Hemolytic Anemia 23:24 Testing for Underlying Causes of Autoimmune Hemolytic Anemia 24:40 Association of Autoimmune Hemolytic Anemia with Lymphomas 25:10 Autoimmune Hemolytic Anemia: Diagnosis and Treatment 26:06 Management Approach for Autoimmune Hemolytic Anemia 27:30 Considerations for Outpatient Treatment of Autoimmune Hemolytic Anemia 28:18 Clotting Risk in Autoimmune Hemolytic Anemia 29:20 Treatment Options for Autoimmune Hemolytic Anemia 30:42 Long-Term Prognosis and Recurrence of Autoimmune Hemolytic Anemia 33:32 Diagnostic Challenges in Myelodysplastic Syndrome 35:00 Considerations for Folate Supplementation 36:24 Factors to Consider in the Management of Myelodysplastic Syndrome 39:30 When to Perform a Bone Marrow Biopsy in Myelodysplastic Syndrome 41:25 Shared Decision-Making in the Treatment of Myelodysplastic Syndrome Credits Writer and Producer: Matthew Watto MD, FACP Show Notes: Matthew Watto MD, FACP Cover Art and Infographic: Matthew Watto MD, FACP Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Fatima Syed MD, MSc Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Rakhi P. Naik MD, MHS Sponsor: Beginly Health Visit beginlyhealth.com/curbsiders job matching platform for every Physician and Advanced Practice Clinician, from training to practice. Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. Sponsor: Babbel Get up to 60% off your Babbel subscription, for a limited time, at Babbel.com/CURB.
© 2020-2025 Ivy Podcast Discovery LLC
